230 related articles for article (PubMed ID: 8114007)
1. Effects of chronic U50,488H treatment on binding and mechanical responses of the rat hearts.
Xia Q; Sheng JZ; Tai KK; Wong TM
J Pharmacol Exp Ther; 1994 Feb; 268(2):930-4. PubMed ID: 8114007
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart.
Zhang WM; Wang HX; Xia Q; Wong TM
Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688
[TBL] [Abstract][Full Text] [Related]
3. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
Yu XC; Wang HX; Pei JM; Wong TM
J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
[TBL] [Abstract][Full Text] [Related]
4. Role of protein kinase C-epsilon in the development of kappa-opioid receptor tolerance to U50,488H in rat ventricular myocytes.
Zhou JJ; Bian JS; Pei JM; Wu S; Li HY; Wong TM
Br J Pharmacol; 2002 Apr; 135(7):1675-84. PubMed ID: 11934807
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart.
Cheng L; Ma S; Wei LX; Guo HT; Huang LY; Bi H; Fan R; Li J; Liu YL; Wang YM; Sun X; Zhang QY; Yu SQ; Yi DH; Ma XL; Pei JM
Heart Vessels; 2007 Sep; 22(5):335-44. PubMed ID: 17879026
[TBL] [Abstract][Full Text] [Related]
6. kappa -opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+)exchange pathway.
Bian JS; Pei JM; Cheung CS; Zhang WM; Wong TM
J Mol Cell Cardiol; 2000 Aug; 32(8):1415-27. PubMed ID: 10900168
[TBL] [Abstract][Full Text] [Related]
7. [Delayed electrical uncoupling is involved in kappa-opioid receptor activation -induced cardioprotective effect in the isolated rat heart].
Chen BP; Fan FY; Mao HJ; Xia Q
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 Feb; 22(1):64-70. PubMed ID: 21186583
[TBL] [Abstract][Full Text] [Related]
8. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes-cross-talk between kappa-opioid and beta-adrenergic receptors.
Yu XC; Li HY; Wang HX; Wong TM
J Mol Cell Cardiol; 1998 Feb; 30(2):405-13. PubMed ID: 9515017
[TBL] [Abstract][Full Text] [Related]
9. L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats.
Gullapalli S; Ramarao P
Neuropharmacology; 2002 Mar; 42(4):467-75. PubMed ID: 11955518
[TBL] [Abstract][Full Text] [Related]
10. [The study of effects and mechanism of U50, 488H on electrical coupling during ischemia in the perfused isolated rat heart].
Mao HJ; Chen BP; Wang HP; Gao YF; Xia Q
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 Aug; 26(3):261-5. PubMed ID: 21038665
[TBL] [Abstract][Full Text] [Related]
11. Chronic U50,488H abolishes inositol 1,4,5-trisphosphate and intracellular Ca2+ elevations evoked by kappa-opioid receptor in rat myocytes.
Sheng JZ; Wong TM
Eur J Pharmacol; 1996 Jul; 307(3):323-9. PubMed ID: 8836621
[TBL] [Abstract][Full Text] [Related]
12. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
Brent PJ
Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
[TBL] [Abstract][Full Text] [Related]
14. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
[TBL] [Abstract][Full Text] [Related]
15. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
16. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
[TBL] [Abstract][Full Text] [Related]
17. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure.
Joseph DB; Bidlack JM
J Pharmacol Exp Ther; 1995 Mar; 272(3):970-6. PubMed ID: 7891351
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation.
Li JG; Benovic JL; Liu-Chen LY
Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950
[TBL] [Abstract][Full Text] [Related]
19. U50,488H inhibits neutrophil accumulation and TNF-α induction induced by ischemia-reperfusion in rat heart.
Wu X; Zhang B; Fan R; Zhao L; Wang Y; Zhang S; Kaye AD; Huang L; Pei J
Cytokine; 2011 Nov; 56(2):503-7. PubMed ID: 21843951
[TBL] [Abstract][Full Text] [Related]
20. Delayed uncoupling is related to cardioprotection induced by kappa-agonist U-50,488H in rat heart.
Chen BP; Mao HJ; Fan FY; Bruce IC; Xia Q
Scand Cardiovasc J; 2005 Dec; 39(6):375-82. PubMed ID: 16352491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
